Patriot Scientific

Patriot Scientific Reports Profitable Quarter; Q3 FY '08 Net Income $6.3 Million or $0.02 Basic and Diluted Earnings Per Share.
in response to BaNosser's message

<Best case senario imo (wtfdik) would be the MA/CA being ammended to the point where PTSC has greater control and power.. to at least equal to that of Leckerone/TPL.. with appropriate system control/monitoring.. and no Core/Flash/MMP portfolio combined licensing...>

That certainly sounds good and seems to be a good result for PTSC. But is it feasible?

If Alliacense is still negotiating MMP licenses and still a part of TPL, how does PTSC find out that the MMP was being undercut for the benefit of a TPL sale? PTSC probably knew this was going on for qulite some time. But proving it is an entirely different story. You need someone from Alliacense or the liceensee to come forward, and there is no incentive for them to do so. The present proof may well have been accidently discovered as part of other litigation.

Since it is most unlikely TPL can be barred from licensing other IP, is the best case scenario, as defined above, really feasible?

Opty

Please login to post a reply
optymystic
City
Rank
President
Activity Points
18922
Rating
Your Rating
Date Joined
11/02/2006
Social Links
Private Message
Patriot Scientific
Symbol
PTSC
Exchange
OTCBB
Shares
401,392,948
Industry
Technology & Medical
Website
Create a Post